Beam Therapeutics (BEAM) Change in Acquisitions & Divestments (2019 - 2026)

Beam Therapeutics (BEAM) has 8 years of Change in Acquisitions & Divestments data on file, last reported at $181.3 million in Q1 2026.

• On a quarterly basis, Change in Acquisitions & Divestments fell 16.51% year-over-year to $181.3 million in Q1 2026; TTM through Mar 2026 was $806.6 million, a 1006.04% increase from a year earlier, with the FY2025 full-year figure at $842.5 million, changed N/A from the prior year.
• Change in Acquisitions & Divestments for Q1 2026 stood at $181.3 million, down from $836.7 million in the prior quarter.
• Over the last five years, Change in Acquisitions & Divestments for BEAM reached as high as $836.7 million in Q4 2025 and fell as low as -$935.0 million in Q4 2023.
• Historically, Change in Acquisitions & Divestments has averaged $139.3 million across 5 years, with a median of $220.5 million in 2024.
• Across the five-year window, Change in Acquisitions & Divestments surged 683.91% in 2022 and sank 359.64% in 2023, its largest moves.
• Year by year, Change in Acquisitions & Divestments stood at $360.1 million in 2022, then slumped by 359.64% to -$935.0 million in 2023, then jumped by 60.62% to -$368.1 million in 2024, then soared by 327.29% to $836.7 million in 2025, then plunged by 78.33% to $181.3 million in 2026.
• Per Business Quant data, the three most recent Change in Acquisitions & Divestments figures were $181.3 million in Q1 2026, $836.7 million in Q4 2025, and -$378.1 million in Q3 2025.